Oman: MoH launches EBS project, public health empowerment programme
Dr Amal al Ma'ani, MoH's Director-General of Centre for Disease Control and Prevention, emphasised that this achievement comes as part of a national initiative aimed at strengthening the early warning system and rapid response to health events, in alignment with Oman Vision 2040, which places human health and safety at the core of its priorities. She stated that Event-Based Surveillance is not just a system — it rather represents a qualitative leap towards smart and early detection of unconventional health signals, through integration among the health, environmental and animal sectors, and by activating the 'One Health' approach.
Dr Heather Burke, the Regional Director of the Middle East and North Africa for the US Centers for Disease Control and Prevention, gave a presentation in which she stated: 'We are proud to see this system now being implemented across all governorates of the Sultanate of Oman to support the already well-established Indicator-Based Surveillance system. We are confident that this system will further enhance Oman's position as a model for early warning and response systems, thereby strengthening epidemic intelligence in the country.'
Dr Adel al Wahaibi, Director of Epidemiological Surveillance in the Ministry of Health, highlighted the Event-Based Surveillance (EBS) project. He discussed its concept, the differences between it and the Indicator-Based Surveillance system and its components. He highlighted Oman's efforts to develop this system, which include the creation of a national electronic platform, the preparation of operational manuals and standardised forms, conducting a pilot study in Al Sharqiyah North and Al Dakhiliyah governorates, and training personnel, following the 'One Health' approach.
Dr Abdullah al Manji, Epidemiologist at the Centre for Disease Control and Prevention, explained that the programme serves as an applied educational platform that combines both theoretical and field-based learning. This programme has resulted in the graduation of four cohorts of national competencies so far, serving as a successful model for enhancing the national readiness to tackle health challenges.
These initiatives aim to enhance early warning capabilities for health threats, particularly in light of growing epidemiological and health challenges at both local and global levels.
The Event-Based Surveillance project represents a strategic transformation in Oman's epidemiological monitoring system. It is designed to enhance the health system's capacity for early detection of health threats and effective response.
This project complements the Indicator-Based Surveillance (IBS) programme, reinforcing the concept of 'epidemiological vigilance' across Oman. EBS works by collecting and analysing data from a wide range of sources, including health centres, schools and local communities, while leveraging modern technology to improve operational efficiency and the overall effectiveness of the system.
The Field Epidemiology Training Programme (FETP) is designed to strengthen the skills of professionals working in the health sector and related fields by developing their capabilities in disease surveillance, health data analysis and outbreak investigation.
2022 © All right reserved for Oman Establishment for Press, Publication and Advertising (OEPPA) Provided by SyndiGate Media Inc. (Syndigate.info).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
a day ago
- Zawya
Cameroon Takes Bold Steps to Revitalize Emergency Medical Services
Cameroon is embarking on a transformative journey to revamp its emergency medical services (EMS) system, marking a significant milestone in public health. The Ministry of Public Health, with the unwavering support of the World Health Organization (WHO) and the Korean International Cooperation Agency (KOICA), has validated the 2024 evaluation report that sheds light on the critical state of emergency care across the nation. Conducted from September 1st to October 30th, 2024, and validated in April 2025, the assessment utilized the WHO Emergency and Critical Care System Assessment (ECCSA) tool, systematically analysing the core pillars essential for emergency care. These foundational areas included governance and financing, data and quality improvement, onsite care and transport, hospital-based care and rehabilitation, and emergency preparedness. The participatory approach taken during the assessment drew insights from over 170 diverse stakeholders from all ten regions of Cameroon, ensuring that local voices shaped the findings and recommendations. Even the report's translation into English was performed by a dedicated team of experts to promote inclusivity and foster ownership of the outcomes. Identifying Systemic Weaknesses Despite efforts to deliver emergency services, the ECCSA evaluation uncovered urgent gaps that need to be bridged. Key findings include a troubling the absence of both a strategic plan and a legal framework for emergency care, lack of trained emergency technicians and ambulance drivers, with the current prehospital care coverage estimated at a mere 25%. Furthermore, less than one-quarter of hospitals meet basic functional emergency unit standards, highlighting significant infrastructural deficits. The absence of a national system for standardized patient records, fragmented emergency numbers lacking legal mandates, and restrictions on timely access to emergency blood transfusion are alarming deficiencies that compromise patient outcomes. Additionally, the report noted the absence of a dedicated strategic framework for rehabilitation services, which are essential for holistic recovery following emergency incidents. Strategic Priorities for Reform In response to these alarming findings, the Ministry of Public Health has embraced a comprehensive roadmap consisting of 15 strategic priorities categorized under five thematic areas. Among these priorities is the development of a national strategic plan aimed at optimizing the organization of emergency care services throughout the country. The establishment of a robust legal framework that encompasses community, prehospital, hospital, and rehabilitation care will be a pivotal step forward. Moreover, the creation of a dedicated fund for emergency response signifies a commitment to sustainable financing of these essential services. Key initiatives will also include the design of a data management guide to facilitate the collection and use of emergency care data, as well as the launch of comprehensive training programs for health professionals on emergency response protocols. Emphasizing logistics and accessibility, there will be a renewed focus on strengthening transport systems and enhancing the availability of ambulances. The Ministry is committed to building the capacity of emergency care professionals and ensuring a reliable supply chain for emergency medicines and materials. By defining and implementing care standards across all facility levels, the Ministry aims to guarantee that every citizen receives timely and effective care when they need it most. As Cameroon charts this ambitious course toward reforming its emergency care system, it is crucial for all stakeholders to engage collaboratively in this life-saving endeavour. With effective implementation of set priorities, Cameroon can aspire towards a more responsive and resilient emergency care system, ultimately enhancing health outcomes for its population. Distributed by APO Group on behalf of World Health Organization (WHO) - Cameroon.
Zawya
a day ago
- Zawya
Omani research team uses AI to detect genetic heart disorders
Muscat: A groundbreaking research initiative has made significant progress in identifying the genetic causes of cardiomyopathy in the Sultanate of Oman. The study, titled 'Implementation of Machine Learning Approach to Predict Pathogenicity of Genetic Variants Associated with Cardiomyopathy,' utilises Whole Exome Sequencing (WES) and advanced Artificial Intelligence (AI) methodologies to investigate the underlying genetic contributors to this complex heart condition. The research was led by Dr. Ahmed Al Amri, Consultant of Molecular Genetics Lab and Head of Training and Professional Staff Development at the National Genetics Centre of the Royal Hospital. Cardiomyopathy, a heterogeneous group of myocardial disorders, remains a significant health burden worldwide. In the Sultanate of Oman, the genetic basis of the disease has been insufficiently characterised, hindering effective diagnosis and intervention. This study aimed to bridge that gap by conducting genetic analysis on a cohort of Omani families affected by cardiomyopathy. Dr. Ahmed Al Amri explained that central to the research is the development of a novel AI-based analysis model called 'CardioVar.' This model is designed to enhance the interpretation of WES data through the integration of more than 50,000 genetic variants and mutations linked to cardiomyopathy, supported by multiple AI algorithms to ensure analytical precision. The research project achieved a diagnostic success rate of over 80%, uncovering both known and previously unreported genetic mutations, some of which involve genes not previously linked to cardiomyopathy. These findings offer valuable insight into the genetic landscape of the disease within the Omani population and present new opportunities for further research to confirm the clinical relevance of novel variants. The AI model significantly improved both the speed and accuracy of genetic analysis, demonstrating its practical value in overcoming the limitations of traditional sequencing approaches. Dr. Al Amri emphasised that this approach not only advances the understanding of the genetic basis of cardiomyopathy in the Sultanate of Oman but also provides a scalable framework for implementing AI in genomic medicine, enhancing diagnostic accuracy and personalised care. The multidisciplinary research team included Dr. Ahmed Al Amri, Dr. Aisha Al Balushi, Nibras Al Mahrami, Dr. Musallam Al Ariami, Dr. Nadia Al Hashimi, Dr. Mohammed Al Rawahi, Dr. Tuqa Al Lawati, Dr. Bushra Al Shamsi, Dr. Fahad Al Hattali, and Ms. Mashael Al Balushi. Together, they have contributed to a practical model that blends clinical knowledge, laboratory science, and artificial intelligence to achieve high-impact results. This research not only advances the scientific understanding of inherited cardiomyopathy in the Sultanate of Oman but also exemplifies how AI can transform genetic diagnostics. It stands as a national model for the integration of precision medicine into routine clinical care, with plans to expand the study to include other hereditary heart conditions and incorporate its findings into everyday healthcare practices. © Muscat Media Group Provided by SyndiGate Media Inc. (
Gulf Business
5 days ago
- Gulf Business
UAE sets new standards for next-generation oral products
Credit: Getty Images In this interview, Alexandre Ghanem, Cluster Head of Middle East & North Africa (MENA) at BAT, discusses the significance of the new rules, how they align with global harm reduction efforts, and BAT's plans to launch a new portfolio in the UAE. Pictured: Alexandre Ghanem, Cluster Head of Middle East & North Africa (MENA) at BAT. What are BAT's plans for the UAE with this new regulatory framework in mind? The UAE's decision to issue regulatory requirements for tobacco-free oral nicotine pouches aligns with BAT's transformation and our vision of creating 'A Better Tomorrow'—a smokeless world driven by reducing the health impact of our business. Tobacco Harm Reduction (THR) as a policy encourages adult consumers who would otherwise continue to smoke to switch to lower-risk alternatives. Adult smokers and nicotine users in the UAE are progressive and open to innovative products. The UAE standard now provides access to high-quality alternatives, which is why BAT plans to introduce a new portfolio of tobacco-free oral nicotine pouches under the VELO brand in the market, in line with our THR ambitions. How significant is regulating tobacco-free oral nicotine pouches to harm reduction in the UAE? The UAE continues to lead in regulatory innovation. The Ministry of Industry and Advanced Technology's (MoIAT) decision to issue a technical standard for tobacco-free oral nicotine pouches reflects a strong commitment to public health and quality control. It is widely accepted that most harm from smoking comes from inhaling the smoke produced by burning tobacco—not from nicotine itself. Tobacco-free oral nicotine pouches, being smokeless and tobacco-free, present a reduced-risk profile when compared to combustible products, assuming a complete switch from smoking. How effective has the launch of BAT's tobacco-free nicotine pouches been elsewhere? Can that success be replicated in the UAE? Our tobacco-free nicotine pouches are currently available in over 40 countries, with 7.4 million adult consumers globally. VELO products are developed under rigorous stewardship and have been shown to contain 90–99 per cent fewer toxic chemicals compared to cigarette smoke. The broader category of oral nicotine pouches has contributed significantly to global public health by reducing smoking rates. Sweden is a notable example, where oral nicotine has largely replaced smoking over the past 70 years, resulting in the lowest smoking rate and lung cancer mortality rate in Europe—29.1 deaths per 100,000 compared to the EU average of 66.7 (2020 data). As of 2024, Sweden's smoking rate stands at 5.3 per cent, positioning it to achieve the WHO's 'smoke-free' status and putting the country 15 years ahead of the EU's 2040 target. Where do tobacco-free oral nicotine pouches fall on the risk continuum compared to cigarettes? Leading health bodies, including the US FDA, acknowledge that the main causes of smoking-related diseases are the harmful chemicals in tobacco smoke—not nicotine itself. In 2008, the WHO identified nine key toxicants in cigarette smoke. In VELO products, these are reduced by more than 99 per cent. While smokers may be addicted to nicotine, nicotine itself is not classified as a carcinogen. The Royal College of Physicians in London reinforces this, noting that the real danger lies in the smoke. If nicotine can be delivered in an effective and acceptable smokeless form, such as oral pouches, most—if not all—of the harm from smoking could potentially be avoided.
